BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18698080)

  • 21. Molecular biology of Burkitt's lymphoma.
    Hecht JL; Aster JC
    J Clin Oncol; 2000 Nov; 18(21):3707-21. PubMed ID: 11054444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges in the management of Burkitt's lymphoma.
    Levine AM
    Clin Lymphoma; 2002 Dec; 3 Suppl 1():S19-25. PubMed ID: 12521385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescent in situ hybridization for the detection of t(8:14) in Burkitt's lymphoma.
    Lishner M; Kenet G; Lalkin A; Yarkoni S; Ben-Bassat H; Fejgin M; Rechavi G; Amiel A
    Acta Haematol; 1993; 90(4):186-9. PubMed ID: 8140858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt's lymphomas.
    Syrjänen S; Kallio P; Sainio P; Fuju C; Syrjänen K
    Scand J Dent Res; 1992 Jun; 100(3):176-80. PubMed ID: 1321486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma.
    Nomura Y; Yoshida S; Karube K; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
    Cancer Sci; 2008 Aug; 99(8):1564-9. PubMed ID: 18754867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Undifferentiated non-Hodgkin's lymphomas (Burkitt's and non-Burkitt's types). The relevance of making this histologic distinction.
    Miliauskas JR; Berard CW; Young RC; Garvin AJ; Edwards BK; DeVita VT
    Cancer; 1982 Nov; 50(10):2115-21. PubMed ID: 7127252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma.
    Dictor M; Ek S; Sundberg M; Warenholt J; György C; Sernbo S; Gustavsson E; Abu-Alsoud W; Wadström T; Borrebaeck C
    Haematologica; 2009 Nov; 94(11):1563-8. PubMed ID: 19880779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes.
    Lim T; Kim SJ; Kim K; Lee JI; Lim DH; Lee DJ; Baek KK; Lee HY; Han B; Uhm JE; Ko YH; Kim WS
    Ann Hematol; 2011 Dec; 90(12):1391-8. PubMed ID: 21479535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study.
    García JL; Hernandez JM; Gutiérrez NC; Flores T; González D; Calasanz MJ; Martínez-Climent JA; Piris MA; Lopéz-Capitán C; González MB; Odero MD; San Miguel JF
    Leukemia; 2003 Oct; 17(10):2016-24. PubMed ID: 14513052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of EBV in the pathogenesis of Burkitt's Lymphoma: an Italian hospital based survey.
    Pannone G; Zamparese R; Pace M; Pedicillo MC; Cagiano S; Somma P; Errico ME; Donofrio V; Franco R; De Chiara A; Aquino G; Bucci P; Bucci E; Santoro A; Bufo P
    Infect Agent Cancer; 2014; 9(1):34. PubMed ID: 25364378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pathology of non-Hodgkin's lymphoma of childhood: II. Reproducibility and relevance of the histologic classification of "undifferentiated" lymphomas (Burkitt's versus non-Burkitt's).
    Wilson JF; Kjeldsberg CR; Sposto R; Jenkin RD; Chilcote RR; Coccia P; Exelby RR; Kersey J; Meadows A; Siegel S
    Hum Pathol; 1987 Oct; 18(10):1008-14. PubMed ID: 3653876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 8-14 translocation in a Japanese Burkitt's lymphoma.
    Miyamoto K; Sato J; Miyoshi I; Nishihara R; Terao S; Hara M; Kimura I
    Acta Med Okayama; 1980 Mar; 34(2):139-42. PubMed ID: 6450516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biology and treatment of Burkitt's lymphoma.
    Yustein JT; Dang CV
    Curr Opin Hematol; 2007 Jul; 14(4):375-81. PubMed ID: 17534164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute lymphoblastic leukemia of Burkitt's type (L3 ALL) with 8;22 and 14;18 translocations and absent surface immunoglobulins.
    Gluck WL; Bigner SH; Borowitz MJ; Brenckman WD
    Am J Clin Pathol; 1986 May; 85(5):636-40. PubMed ID: 3486584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of long PCR to detect t(8;14)(q24;q32) translocations in childhood Burkitt's lymphoma and B-ALL.
    zur Stadt U; Hoser G; Reiter A; Welte K; Sykora KW
    Ann Oncol; 1997; 8 Suppl 1():31-5. PubMed ID: 9187426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chromosome changes in the lymphomas.
    Sandberg AA
    Hum Pathol; 1981 Jun; 12(6):531-40. PubMed ID: 6974128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burkitt's lymphoma - a human tumor model system for immunological studies.
    Gunvén P
    Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Unexpected Lymphoma: A Rare Case of Primary Gastric Burkitt's Lymphoma.
    London J; Bulancea S; Wander S; Ponnaiya S; Tisheh L; Jain S; Viswanathan P; Tharayil Z
    J Investig Med High Impact Case Rep; 2024; 12():23247096241253341. PubMed ID: 38767125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burkitt's and non-Burkitt's type lymphoma: clinicopathological and radiological manifestations.
    Tseng WY; Li YW; Su IJ; Lin DT; Huang KM
    J Formos Med Assoc; 1991 Apr; 90(4):357-64. PubMed ID: 1680964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.